Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2018/523 of 28 March 2018 amending Regulation (EU) No 37/2010 to classify the substance fluazuron as regards its maximum residue limit (Text with EEA relevance. )
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 3 June 2018.
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘fluazuron’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Fluazuron Fluazuron All ruminants except bovine and ovine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption Antiparasitic agents/Agents (acting) against ectoparasites’ 7 000 μg/kg Fat 500 μg/kg Liver 500 μg/kg Kidney Bovine 200 μg/kg Muscle NO ENTRY 7 000 μg/kg Fat 500 μg/kg Liver 500 μg/kg Kidney 200 μg/kg Milk Fin fish 200 μg/kg Muscle and skin in natural proportions NO ENTRY
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.